Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland - Seite 3

About FUSE-AI GmbH 

FUSE-AI is a Hamburg-based AI company that specializes in the development of AI-based software solutions in the clinical and medical field. With "Prostate.Carcinoma.ai," the company offers a leading solution for the efficient analysis of prostate MRI images. For more information, visit https://fuse-ai.de 

About T-Systems Switzerland 

T-Systems Switzerland is an internationally leading provider of information and communication technology. The company offers a wide range of services, from digital transformation to cloud services and security solutions. For more information on this cooperation, visit https://www.t-systems.com/de/de/referenzen/cloud-und-infrastructure/fu ... 

Disclaimer 

Some of the information contained in this media release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. Xlife Sciences undertakes no obligation to publicly update or revise any forward-looking statements. 

News Source: Xlife Sciences AG

---

End of Media Release

---

Language:	English
Company:	Xlife Sciences AG
	Talacker 35
	8001 Zürich
	Switzerland
Phone:	[phone]
E-mail:	[e-mail]
Internet:	www.xlifesciences.ch
ISIN:	CH0461929603
Valor:	A2PK6Z
Listed:	SIX Swiss Exchange
EQS News ID:	1872739